The Valley Desk

NCT03939689 · Interventional trial

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Overall registry status Completed

Phase 2

Conditions Cancer of the Prostate, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Progressive mCRPC, Prostatic Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov